Currently, legal actions are being taken against the maker of popular weight loss drug, Ozempic (Semaglutide). Originally approved by the FDA in 2017 , Ozempic is a once-weekly injectable medication to treat Type 2 diabetes in adults. However, years later, it began being prescribed for weight loss. Later, the FDA… ...Read More